Annual cohort features the top 50 medical technology startups from around the world
LOS ANGELES, Tuesday, November 16, 2021 – MedTech Innovator, the largest accelerator of medical devices in the world, today announced that it is now accepting applications from startups and emerging growth companies for its annual Accelerator and Showcase program, which will award up to $500,000 in cash and in-kind prizes. The deadline to apply is January 31, 2022. There is no application fee, and no equity is required from participating companies.
MedTech Innovator’s four-month program features 50 of the industry’s best-in-class medical technologies from around the globe. In 2022, there will be several opportunities for the companies to gain unparalleled exposure to industry executives and decision-makers through online application reviews, pitch sessions, mentoring, conference showcases, and live competitions.
“At MedTech Innovator our mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system,” said Paul Grand, CEO of MedTech Innovator. “This year is no different as we continue our search for the top medical device, digital health, and diagnostic companies and match them with healthcare industry leaders for mentorship and support. With help from our industry partners, we look forward to advancing more transformative products towards commercialization and into the hands of the patients and physicians who need them.”
Applications are reviewed by more than 200 executives and professionals from dozens of leading companies, including manufacturers, providers, and investors such as Johnson & Johnson, RCT Ventures, Asahi Intecc, BD, Dexcom, Edwards Lifesciences, Fujikura, Jabil Healthcare, Maxim Integrated Ventures, NIPRO Medical Corp., Olympus Medical Systems Group, W.L Gore & Associates, and many more. The top applicants will be invited to present at one of MedTech Innovator’s virtual pitch events in the spring of 2022.
“We are excited about the opportunity to continue to mentor and support the companies who are selected for the 2022 cohort with a goal of helping to address critical gaps in today’s healthcare system,” said Susan Morano, vice president, business development and strategic operations for Johnson & Johnson Medical Devices Companies. “Johnson & Johnson is committed to helping patients by accelerating transformative healthcare solutions that improve the current standard of care.”
More than 1,100 companies applied to participate in the 2021 program, which culminated with a final competition on September 29 during The MedTech Conference powered by AdvaMed. Five finalists were selected from the Accelerator program to compete in the grand finale and a live audience vote selected Alva Health as the 2021 Global Competition winner.
Since 2013, MedTech Innovator has reviewed more than 6,000 startups, 422 of which were selected to participate in the program. Alumni have gone on to raise more than $3.5 billion in follow-on funding, bring over 85 products to market, and achieve 21 exits. MedTech Innovator works closely with stakeholders across the industry to promote the growth of early and mid-stage startups. In collaboration with 25 corporate partners, as well as a broader network of more than 200 investors, business development representatives, and industry experts, MedTech Innovator provides startups with individualized mentorship and feedback, funding opportunities, and continual engagement with peers and advisors.
About MedTech Innovator
Based in Los Angeles, Calif., MedTech Innovator is the largest accelerator of medical device companies in the world and the premier nonprofit startup accelerator in the medical technology industry.[i] Its mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. MedTech Innovator matches healthcare industry leaders with innovative early-stage and emerging growth medtech companies for mentorship and support.
MedTech Innovator’s founding sponsors are Johnson & Johnson and RCT Ventures. Annual program sponsors include NIPRO Medical Corp., Olympus Medical Systems Group, Asahi Intecc, BD, Edwards Lifesciences LLC, Dexcom, Fujikura Ltd., Jabil Healthcare, Maxim Integrated Ventures, now a part of Analog Devices, W. L. Gore & Associates, Inc., Experien Group, now a part of Veranex, Greenlight Guru, Integrated Computer Solutions (ICS), Medmarc, Medical Technology Enterprise Consortium (MTEC), Oliver Healthcare Packaging, Proxima Clinical Research, Silicon Valley Bank, Three Bridges Management & Consulting, Westwood & Wilshire, and Ximedica, now a part of Veranex. The organization’s industry partners include AdvaMed, Health+Commerce, MedTech Strategist, and Wilson Sonsini Goodrich & Rosati.
For more information about MedTech Innovator and how to apply for the 2022 Accelerator and Showcase programs, visit https://medtechinnovator.org/ and follow @MedTechAwards on Twitter and on LinkedIn. To receive industry insights and highlights about MedTech Innovator’s current and alumni participant companies, subscribe to its monthly newsletter.
[i] Gibbs, M., Johnson, B., Silva, B. A., & Berube, K. (2020, July 10). Q2 2020 Life Science Accelerators Insights Cipher Bio. Retrieved September 15, 2020, from https://www.cipherbio.com/blog/life-science-accelerators-insights/